MetLife Investment Management’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
19,084
+1,117
+6% +$186K 0.01% 876
2026
Q1
$3.05M Sell
17,967
-396
-2% -$67.2K 0.02% 838
2025
Q4
$2.82M Sell
18,363
-895
-5% -$137K 0.01% 901
2025
Q3
$2.89M Buy
+19,258
New +$3.03M 0.01% 901
2025
Q2
– Sell
-18,817
Closed -$3.12M – 2940
2025
Q1
$3.12M Sell
18,817
-716
-4% -$117K 0.02% 840
2024
Q4
$3.18M Buy
19,533
+1,278
+7% +$222K 0.02% 806
2024
Q3
$3.21M Sell
18,255
-389
-2% -$66.2K 0.02% 780
2024
Q2
$2.87M Buy
18,644
+2,306
+14% +$347K 0.02% 803
2024
Q1
$2.53M Sell
16,338
-438
-3% -$64.9K 0.02% 855
2023
Q4
$2.5M Hold
16,776
– – 0.02% 860
2023
Q3
$2.08M Hold
16,776
– – 0.02% 886
2023
Q2
$2.26M Buy
16,776
+140
+0.8% +$18K 0.02% 889
2023
Q1
$2.1M Hold
16,636
– – 0.02% 896
2022
Q4
$2.03M Sell
16,636
-316
-2% -$41.7K 0.02% 888
2022
Q3
$2.06M Buy
16,952
+410
+2% +$53.4K 0.02% 864
2022
Q2
$2.15M Sell
16,542
-847
-5% -$106K 0.02% 877
2022
Q1
$2.38M Buy
17,389
+6,189
+55% +$887K 0.02% 927
2021
Q4
$1.89M Hold
11,200
– – 0.02% 892
2021
Q3
$1.62M Hold
11,200
– – 0.01% 938
2021
Q2
$1.47M Sell
11,200
-902
-7% -$116K 0.01% 993
2021
Q1
$1.52M Sell
12,102
-954
-7% -$116K 0.01% 963
2020
Q4
$1.5M Hold
13,056
– – 0.01% 951
2020
Q3
$1.27M Sell
13,056
-925
-7% -$90.7K 0.01% 923
2020
Q2
$1.33M Buy
13,981
+657
+5% +$61.4K 0.02% 911
2020
Q1
$1.32M Hold
13,324
– – 0.02% 788
2019
Q4
$1.35M Sell
13,324
-959
-7% -$96.7K 0.01% 955
2019
Q3
$1.42M Hold
14,283
– – 0.02% 914
2019
Q2
$1.43M Sell
14,283
-26,853
-65% -$2.61M 0.02% 951
2019
Q1
$3.82M Buy
41,136
+27,424
+200% +$2.37M 0.01% 958
2018
Q4
$1.07M Hold
13,712
– – 0.01% 989
2018
Q3
$1.54M Sell
13,712
-948
-6% -$99.7K 0.02% 963
2018
Q2
$1.44M Sell
14,660
-12,432
-46% -$1.16M 0.02% 897
2018
Q1
$2.21M Buy
27,092
+12,252
+83% +$964K 0.03% 740
2017
Q4
$1.2M Buy
+14,840
New +$1.24M 0.01% 962

Other funds holding BCPC

MetLife Investment Management's BCPC Position: Q2 2026 in Review

MetLife Investment Management increased its Balchem Corp (BCPC) stake by 6.2% in Q2 2026, buying an estimated $186K and bringing the position to 19,084 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #876.

MetLife Investment Management first reported a position in BCPC in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.82M in Q1 2019. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • MetLife Investment Management held 19,084 shares of Balchem Corp worth $3.22M as of Q2 2026.
  • MetLife Investment Management bought 1,117 Balchem Corp shares in Q2 2026, an estimated $186K.
  • Balchem Corp made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #876 holding.
  • MetLife Investment Management first reported a position in Balchem Corp in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Balchem Corp position peaked at $3.82M in Q1 2019.
  • 417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.